Kim Sablich, EVP & GM, North America at Jazz Pharmaceuticals plc (JAZZ), sold 8,866 shares at $150.68 ($1.3M) on 2022-06-07, disclosed to the SEC on 2022-06-08.
Open-market sale of $1.3M JAZZ by EVP & GM, North America. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.25 | 1,759 | $263K | 19.6% |
| 2 | $152.15 | 1,388 | $211K | 15.8% |
| 3 | $152.15 | 1,388 | $211K | 15.8% |
| 4 | $148.21 | 200 | $30K | 2.2% |
| 5 | $149.22 | 250 | $37K | 2.8% |
| 6 | $150.68 | 573 |
| $86K |
| 6.4% |
| 7 | $150.68 | 573 | $86K | 6.4% |
| 8 | $151.87 | 1,317 | $200K | 14.9% |
| 9 | $151.87 | 1,317 | $200K | 14.9% |
| 10 | $152.60 | 101 | $15K | 1.2% |
| Total | $151.14 avg | 8,866 | $1.3M | 100% |
| Filing → |
| MYOV | SELL | 2020-03-19 | $6K | — | Filing → |
| MYOV | SELL | 2020-01-16 | $136K | — | Filing → |
| MYOV | SELL | 2019-12-19 | $42K | — | Filing → |